Physician Referrals Limiting Treatment of the Venous System

TORONTO, Aug. 25 /PRNewswire/ -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that although venous procedures are set to grow by more than 10% through 2013, a lack of awareness among referring physicians is a major roadblock in increased interventions in the venous system.

Despite this trend, specialists are increasingly adopting new technologies, with 55% of respondents having used pharmacomechanical thrombectomy systems for deep vein thrombosis removal, and 66% performing venous stenting on a regular basis.  The venous system has recently been gaining exposure as an under treated area of the human vasculature. New evidence of clinical success has spurred a trend towards increasingly aggressive interventions both for acute and chronic venous disease. A major contributing factor was the 2008 Surgeon General's Call to Action on Deep Vein Thrombosis and Pulmonary Embolism, but the rise of arterial stents in the venous system has also played a significant role.

"Respondents identified increased education among primary care practitioners as the most important factor that would drive venous stenting," says Stephanie LaBelle, Manager of the Cardiovascular division at MRG. "A third of respondents were unaware of the practice of venous stenting, and 40% do not refer patients for the procedure."

MRG's new Physician Forum publication, Venous Interventions: The Rise of Venous Stenting and Aggressive Deep Vein Thrombosis Treatment is based on 98 US specialists who treat deep vein diseases, and 78 primary care practitioners who refer these patients.  The publication investigates the changing dynamics of the venous interventional market with a specific focus on acute deep vein thrombosis treatment, and the treatment of obstructive chronic deep vein disease with venous stents.

Webinar

On Wednesday September 8, at 11:00 am eastern time, MRG is offering a complimentary webinar with the author of Venous Interventions: The Rise of Venous Stenting and Aggressive Deep Vein Thrombosis Treatment, Manager of the Cardiovascular division, Stephanie LaBelle.  Ms. LaBelle will present an overview of findings from MRG's new study and host a brief Q&A session.  Please contact Amy Krohn at 416-364-7776 ext. 101 or [email protected] to register.

About Physician Forum

Physician Forum assesses physician opinions to get a sense of how market dynamics will shift in response to major events or trends. Publications feature direct feedback from relevant specialists and insight into the impact of events on specific markets. Publications are based on physician interviews and stakeholder surveys.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

SOURCE Millennium Research Group